Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 11 of 11  Show
  1. 1
    "Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro."
    Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.
    DNA Res. 7:65-73(2000) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Brain.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 148 and mapped to 3 other entries.

  2. 2
    "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12931 other entries.

  3. 3
    Category: Sequences.
    Tissue: Fetal brain.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2470 other entries.

  4. 4
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3834 other entries.

  5. 5
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Brain.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50469 other entries.

  6. 6
    "Genomic analysis of synaptotagmin genes."
    Craxton M.A.
    Genomics 77:43-49(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 150-322, TISSUE SPECIFICITY.
    Category: Expression, Sequences.
    Tissue: Brain.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 8 and mapped to 29 other entries.

  7. 7
    "The first C2 domain of human synaptotagmin XIII."
    RIKEN structural genomics initiative (RSGI)
    Submitted (NOV-2004) to the PDB data bank
    Cited for: STRUCTURE BY NMR OF 155-280.
    Category: Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).
  8. 8
    "Re-expression of tumorigenicity after attenuation of human synaptotagmin 13 in a suppressed microcell hybrid cell line."
    Jahn J.E., Coleman W.B.
    Int. J. Oncol. 32:441-449(2008) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: human SYT13 functions as a liver tumor suppressor gene that complements a molecular defect in rat liver tumor cells resulting in a normalized cellular phenotype in vitro and suppression of tumorigenicity in vivoImported.
    Source: GeneRIF:57586.
  9. 9
    "Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement."
    Uhl G.R., Drgon T., Johnson C., Walther D., David S.P., Aveyard P., Murphy M., Johnstone E.C., Munafo M.R.
    Pharmacogenomics 11:357-367(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Annotation: Associated with CHEMDEPENDENCY: smoking cessation.Imported.
    Source: GAD:600376.

    This publication is mapped to 634 other entries.

  10. 10
    "Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score."
    Rose J.E., Behm F.M., Drgon T., Johnson C., Uhl G.R.
    Mol. Med. 16:247-253(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)Imported.
    Source: GeneRIF:57586.

    This publication is mapped to 11621 other entries.

  11. 11
    "Exogenous expression of synaptotagmin XIII suppresses the neoplastic phenotype of a rat liver tumor cell line through molecular pathways related to mesenchymal to epithelial transition."
    Jahn J.E., Best D.H., Coleman W.B.
    Exp. Mol. Pathol. 89:209-216(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: These studies combine to suggest that SYT13 is a liver tumor suppressor gene and that its function may be mediated through pathways implicated in mesenchymal to epithelial transitionImported.
    Source: GeneRIF:57586.
1 to 11 of 11  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again